EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids

Michael Spedding, Johannes Aerts, Steve Alexander, Aurélie-Gaëlle Bellozzi Woestelandt, Elena Chiricozzi, Alexandre Henriques, Pierre-Marie Lledo, Jean-Philippe Loeffler, Rushika Perera, Frances M Platt, Pierre-François Pradat, Frédérique Rene und 8 weitere

Pharmacological Reviews · 2026

DOI: 10.1016/j.pharmr.2026.100113 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Reviews, 2026. Verfasst von Michael Spedding und 19 weiteren Autor:innen. Beteiligte Einrichtung: Spedding Research Solutions SAS, Le Vesinet, France. Electronic address: michael@speddingresearchsolutions.fr. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, COVID-19, Glycosphingolipids. Die Arbeit nennt 365 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/National Institute of Health NIAID, NIH National Institute of Health /NIA, EU Joint Programme Neurodegenerative Disease Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycosphingolipids (GSLs) play major roles in viral infections by mediating viral entry and egress from cells in lipid rafts; however, GSLs are also important in neurodegenerative diseases. The role of GSLs in acute COVID-19 infection is critical but remains less-studied in the sequelae of long COVID (post-COVID condition); because the same enzymes that regulate GSL metabolism are critical for viral entry and exit, neuromuscular junctions, neurological function, and cellular metabolism, it is important to determine whether long COVID may increase the risk of subsequent neurodegeneration. SARS-CoV-2 infection alters lipid metabolism and oxygen use and can bind to and modify the expression of neurotrophic GSLs such as GM1 ganglioside. GM1 (N-acetylneuraminic acid) is human-specific and probably evolved as a result of a pandemic 3-2.5 million years ago that drove its selection. GM1 functions as a coreceptor with angiotensin-converting enzyme 2 for SARS-CoV-2 while also being a neurotrophin. Viral multiplication takes place in the endoplasmic reticulum/Golgi apparatus, where GSLs are synthesized. This review defines the complex interaction between viruses, GSLs, and neurodegeneration, which provides new perspectives on the interlinked metabolic changes. A European working group has been set up to assess the risks of neurodegeneration with long COVID, based on potential GSL-mediated mechanisms. SIGNIFICANCE STATEMENT: The SARS-CoV-2 pandemic has resulted in a large number of subjects living with long-term consequences (long COVID). Glycosphingolipids and gangliosides are involved in both viral infections and neurodegeneration; hence, it is important to evaluate whether long COVID may increase the risk of neurodegeneration via this route. This study is the result of a European consortium formed to evaluate this possibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesCOVID-19GlycosphingolipidsHumansPost-Acute COVID-19 SyndromeSARS-CoV-2AnimalsPandemicsG(M1) Ganglioside

Substanzen

GlycosphingolipidsG(M1) Ganglioside

Autor:innen und Institutionen

  • Spedding Research Solutions SAS, Le Vesinet, France. Electronic address: michael@speddingresearchsolutions.fr.
  • Medical Biochemistry Department, University of Leiden, Leiden, The Netherlands.
  • Faculty of Medicine & Health Sciences - University of Nottingham, Nottingham, UK.
  • Spedding Research Solutions SAS, Le Vesinet, France.
  • Department of Medical Biotechnology and Translational Medicine - University of Milan, Milan, Italy.
  • Neuro-Sys, Gardanne, Provence, France.

Förderung

  • NIH/National Institute of Health NIAID
  • NIH National Institute of Health /NIA
  • EU Joint Programme Neurodegenerative Disease Research
  • National Institute of Allergy and Infectious Diseases
  • Université Catholique de Louvain
  • UCLH Biomedical Research Centre
  • National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Spedding, M., Aerts, J., Alexander, S., Bellozzi Woestelandt, A. G., Chiricozzi, E., Henriques, A., Lledo, P. M., Loeffler, J. P., Perera, R., Platt, F. M., Pradat, P. F., Rene, F., Schapira, A., St Clair, L., Talbot, K., Taquet, M., Toborek, M., Turner, B., Zandi, M., & Gressens, P. (2026). Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids. Pharmacological Reviews. https://doi.org/10.1016/j.pharmr.2026.100113

Vancouver

Spedding M, Aerts J, Alexander S, Bellozzi Woestelandt AG, Chiricozzi E, Henriques A, et al. Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids. Pharmacological Reviews. 2026. doi:10.1016/j.pharmr.2026.100113

BibTeX
@article{Spedding2026,
  author = {Spedding, Michael and Aerts, Johannes and Alexander, Steve and Bellozzi Woestelandt, Aurélie-Gaëlle and Chiricozzi, Elena and Henriques, Alexandre and Lledo, Pierre-Marie and Loeffler, Jean-Philippe and Perera, Rushika and Platt, Frances M and Pradat, Pierre-François and Rene, Frédérique and Schapira, Anthony and St Clair, Laura and Talbot, Kevin and Taquet, Maxime and Toborek, Michal and Turner, Bradley and Zandi, Michael and Gressens, Pierre},
  title = {Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids},
  journal = {Pharmacological Reviews},
  year = {2026},
  doi = {10.1016/j.pharmr.2026.100113}
}
Kostenlos starten →